Fundraising Fox
Harton Therapeutics
Founded 2021 · 11 employees on LinkedIn · 2 known investors
Find your way into Harton Therapeutics
Sign up to see every warm intro you have to Harton Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Harton Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Harton Therapeutics offers a GMP-ready platform for advanced 3D cell manufacturing, using a perfusion-based single-use cartridge system with automated process control to produce human cells at scale. It serves researchers, biotech and pharma teams, and manufacturing partners working on immune cell therapies, HSPCs, engineered cells, and stem-derived cells and tissues.
Investors · 2
Frequently asked questions
- What does Harton Therapeutics do?
- Harton Therapeutics offers a GMP-ready platform for advanced 3D cell manufacturing, using a perfusion-based single-use cartridge system with automated process control to produce human cells at scale. It serves researchers, biotech and pharma teams, and manufacturing partners working on immune cell therapies, HSPCs, engineered cells, and stem-derived cells and tissues.
- Who are Harton Therapeutics's investors?
- Harton Therapeutics's investors include Decheng Capital, The Engine Ventures.